Flavonoids as Cycline-Dependent Kinase Inhibitors: Inhibition of cdc 25 Phosphatase Activity by Flavonoids Belonging to the Quercetin and Kaempferol Series

Abstract

In an effort to detect potential inhibitors of cdc25 phosphatase, nineteen flavonoids belonging to the quercetin and kaempferol series have been evaluated, using a colorimetric assay of recombinant human cdc25A tyrosine phosphatase as a cell cycle-specific target. Compounds bearing two benzyl or methyl groups in positions 7 and 4′ and acetyl on the hydroxy groups of the sugar moiety showed the maximal activity.

References

• 1 Hengst L, Dulic V, Slingerland J M, Lees E, Reed S T. A cell cycle-regulated inhibitor of cyclin-dependent kinanes.  Proceedings of the National Academy of Sciences of the United States of America. 1994;  91 5291-5
• 2 Murray A W, Kirschner M W. Dominoes and clocks: the union of two views of the cell cycle.  Science. 1989;  246 614-21
• 3 Nurse P. Universal control mechanism regulating onset of M-phase.  Nature. 1990;  344 503-8
• 4 Baratte B, Meijer L, Galactionov K, Beach D. Screening for antimitotic compounds using the cdc25 tyrosine phosphatase, an activator of the mitosis-inducing p34^cdc2/cyclin B^cdc13 protein kinase.  Anticancer Research. 1992;  12 873-80
• 5 Rosenblatt J, De Bondt H, Jancarik J, Morgan D O, Kim S-H. Purification and crystallization of human cyclin-dependent kinase 2.  The Journal of Molecular Biology. 1993;  230 1317-9
• 6 Forsburg S L, Nurse P. Cell cycle regulation in the yeasts Saccharomyces cerevisiae and Schizosaccharomyces pombe .  Annual Reviews of Cell Biology. 1991;  7 227-56
• 7 Lee M G, Nurse P. Complementation used to clone a human homologue of the fission yeast cell cycle control gene cdc2.  Nature. 1987;  327 31-5
• 8 Pines J, Hunter T. Isolation of a human cyclin cDNA: evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2.  Cell. 1989;  58 833-46
• 9 Rialet V, Meijer L. A new screening test for antimitotic compounds using the universal M phase-specific protein kinase, p34^cdc2/cyclin B^cdc13, affinity-immobilized on p13^suc1-coated microtitration plates.  Anticancer Research. 1990;  11 1581-90
• 10 Vesely J, Havlicek L, Strnad M, Blow J J, Donella-Deana A, Pinna L, Letham D S, Kato J, Detivaud L, Leclerc S, Meijer L. Inhibition of cyclin-dependent kinases by purine analogues.  European. Journal of the Biochemistry. 1994;  224 771-86
• 11 Sherr C J. Mammalian G1 cyclins.  Cell. 1993;  73 1059-65
• 12 Traganos F, Ardelt B, Halko N, Bruno S, Darzynkiewicz Z. Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukmic MOLT-4 and HL-60 cells.  Cancer Research. 1992;  52 6200-8
• 13 Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fuami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases.  The Journal of Biological Chemistry. 1987;  262 5592-5
• 14 Yoshida M, Yamamoto M, Nikaido T. Quercetin arrests human leukemic T-cells in late G1 phase of the cell cycle.  Cancer Research. 1992;  52 6676-81
• 15 Matsukawa Y, Marui N, Sakai T, Satomi Y, Yoshida M, Matsumoto K, Nishino H, Aoike A. Genistein arrests cell cycle progression at G2-M.  Cancer Research. 1993;  53 1328-31
• 16 De Azevedo W F, Mueller-Dieckmann H-J, Schulze-Gahmen U, Worland P J, Sausville E, Kim S-H. Structural basis for specifity and potency of a flavonoid inhibitor of human CDK2, a cell cycle Kinase.  Proceedings of the National Academy of Sciences of the United States of America. 1996;  93 2735-40
• 17 Losiewicz M D, Carlson B A, Kaur G, Sausville E A, Worland P J. Potent inhibition of cdc2 kinase activity by the flavonoid L86-8275.  Biochemical and Biophysical Research Communications. 1994;  201 589-95
• 18 Mitrocotsa D, Mitaku S, Demetzos C, Harvala C, Mentis A, Perez S, Kokkinopoulos D. Bioactive compounds from the buds of Platanus orientalis and isolation of a new kaempferol glycoside.  Planta Medica. 1993;  59 517-20
• 19 Jurd L, The selective alkylation of polyphenols. Methylation of 7-, 4′-, and 3′-hydroxy groups in flavonols. The Journal of Organic Chemistry. 1962;  27 1294-7
• 20 Demetzos C, Skaltsounis A L, Tillequin F, Koch M. Phase-transfer-catalyzed synthesis of flavonoid glycosides.  Carbohydrate Research. 1990;  207 131-7
• 21 Gray N, Detivaud L, Doerig C, Meijer L. ATP-site directed inhibitors of cyclin-dependent kinases.  Current Medicinal Chemistry. 1999;  6 1-17